Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
MGUS Clinical Trials
Multiple Myeloma Support + Trials
New IMWG Criteria Reflect Change in Practice - Clinical Oncology News
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders | American Society of Clinical Oncology Educational Book
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) | Leukemia
Screening and Early Intervention Trials for Precursor Conditions - Dana-Farber Cancer Institute | Boston, MA
INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma | Future Oncology
Meeting Library | Psychosocial effects of the relaxation response resiliency program (SMART-3RP) in patients with MGUS and smoldering multiple myeloma: A waitlist controlled randomized clinical trial.
Table 2 from Monoclonal gammopathy of undetermined significance. | Semantic Scholar
MC Community Event: Clinical Trials for High Risk Smoldering Myeloma Patients
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies | Blood Cancer Journal
MGUS Clinical Trials
Screening for Monoclonal Gammopathy of Undetermined Significance: First Results from the iStopMM Study
Multiple myeloma - The Lancet
CRO Perspectives: Driving Innovation, Consistency and Reliability in Multiple Myeloma Clinical Trials - Insights From Our Labs to Yours
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies | Blood Cancer Journal
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Future Directions in the Evaluation and Treatment of Precursor Plasma Cell Disorders | American Society of Clinical Oncology Educational Book
Multiple myeloma | Nature Reviews Disease Primers
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
